These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3048009)

  • 21. Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant.
    Webster RG; Taylor J; Pearson J; Rivera E; Paoletti E
    Avian Dis; 1996; 40(2):461-5. PubMed ID: 8790900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin.
    Boyle DB; Selleck P; Heine HG
    Aust Vet J; 2000 Jan; 78(1):44-8. PubMed ID: 10736685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Avian Paramyxovirus Serotypes 2, 6, and 10 as Vaccine Vectors for Highly Pathogenic Avian Influenza in Chickens with Antibodies Against Newcastle Disease Virus.
    Tsunekuni R; Hikono H; Tanikawa T; Kurata R; Nakaya T; Saito T
    Avian Dis; 2017 Sep; 61(3):296-306. PubMed ID: 28957006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert.
    Swayne DE; Garcia M; Beck JR; Kinney N; Suarez DL
    Vaccine; 2000 Jan; 18(11-12):1088-95. PubMed ID: 10590330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.
    Beard CW; Schnitzlein WM; Tripathy DN
    Avian Dis; 1991; 35(2):356-9. PubMed ID: 1649592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
    Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
    Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.
    Bertran K; Balzli C; Lee DH; Suarez DL; Kapczynski DR; Swayne DE
    Vaccine; 2017 Nov; 35(46):6336-6344. PubMed ID: 28554502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
    Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
    Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection.
    Wood JM; Kawaoka Y; Newberry LA; Bordwell E; Webster RG
    Avian Dis; 1985; 29(3):867-72. PubMed ID: 4074253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
    Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
    Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.